{"id":"W3009099064","doi":"10.1200/jco.19.03136","title":"Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non–Small-Cell Lung Cancer","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1154,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Hôpital Charles-Le Moyne","funders":"","keywords":"Pemetrexed; Medicine; Pembrolizumab; Lung cancer; Internal medicine; Hazard ratio; Placebo; Oncology; Progression-free survival; Response Evaluation Criteria in Solid Tumors; Surgery; Cancer; Progressive disease; Chemotherapy; Confidence interval; Pathology; Immunotherapy; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008134195,0.001317069,0.003929759,0.001221455,0.0003247976,0.001617596,0.001335328,0.001037736,0.0117489],"category_scores_gemma":[0.01195274,0.000723857,0.009599088,0.001685517,0.00025417,0.001295991,0.001107672,0.002274224,0.001410549],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001600803,"about_ca_system_score_gemma":0.001672184,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003240621,"about_ca_topic_score_gemma":0.007268632,"domain_scores_codex":[0.9939179,0.003290142,0.0005954698,0.000743755,0.001142197,0.000310468],"domain_scores_gemma":[0.9936399,0.002488716,0.001848956,0.0007784866,0.0009074987,0.0003365757],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7076643,0.001220295,0.01609198,0.01506324,0.1020061,0.0002587469,0.0001324178,0.003465297,0.005128681,0.000762166,0.06820032,0.08000656],"study_design_scores_gemma":[0.3827682,0.03799922,0.1781381,0.002903207,0.2766388,0.0009868219,0.0001556096,0.003382353,0.003978368,0.001327628,0.1114632,0.000258497],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5188974,0.1184525,0.008549722,0.004001757,0.003784005,0.01472206,0.2948784,0.001172984,0.03554117],"genre_scores_gemma":[0.8139512,0.01648247,0.007222956,0.006304524,0.001341772,0.006087393,0.1366208,0.0004757408,0.01151323],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0117489,"threshold_uncertainty_score":0.04301828,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1020767828221736,"score_gpt":0.432874076965801,"score_spread":0.3307972941436275,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}